Pathophysiology of pre-eclampsia: update on the role of nitric oxide.

Abstract:

:Women with chronic hypertension and pregnancy-induced hypertension are at substantial risk for developing pre-eclampsia/eclampsia, a disease with high fetomaternal morbidity and mortality. However, the etiology of this disease is still unknown. In this article, recent concepts on the pathophysiology of pre-eclampsia, with special attention to the role of nitric oxide, are reviewed.

journal_name

Curr Hypertens Rep

authors

Kashiwagi M,Zimmermann R,Beinder E

doi

10.1007/s11906-003-0057-2

keywords:

subject

Has Abstract

pub_date

2003-12-01 00:00:00

pages

493-7

issue

6

eissn

1522-6417

issn

1534-3111

journal_volume

5

pub_type

杂志文章,评审
  • Renal nerves in the maintenance of hypertension: a potential therapeutic target.

    abstract::Renal sympathetic efferent and afferent nerves, which lie within and immediately adjacent to the wall of the renal arteries, contribute to the maintenance of hypertension. Because the causative factors of hypertension change over time, denervation of both efferent and afferent renal nerves should result in long-term a...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-010-0108-4

    authors: Katholi RE,Rocha-Singh KJ,Goswami NJ,Sobotka PA

    更新日期:2010-06-01 00:00:00

  • Hot Topic: Global Burden of Treating Hypertension-What is the Role of the Emergency Department?

    abstract::Hypertension (HTN) is the most common modifiable risk factor for cardiovascular disease (CVD) morbidity and mortality worldwide. Lower- and middle-income countries (LMICs) are projected to bear the vast majority of this disease burden, but local and regional health care delivery systems in these countries are ill equi...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-017-0707-4

    authors: Brody AM,Kumar VA,Levy PD

    更新日期:2017-01-01 00:00:00

  • Dual blockade of the renin angiotensin system in diabetic and nondiabetic kidney disease.

    abstract::Dual blockade of the renin angiotensin system is based on a principle of obtaining the broadest and most efficient blockade of the effects of angiotensin II, by using the combination of an angiotensin-converting enzyme (ACE) inhibitor and an angiotensin II-receptor blocker (ARB). By combining two, different pharmacolo...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-004-0056-y

    authors: Andersen NH,Mogensen CE

    更新日期:2004-10-01 00:00:00

  • Issues of clinical trial design and data interpretations in hypertension.

    abstract::There are many drug studies for the treatment of hypertension. Most studies compare one drug with another to determine if a drug or class of drugs have unique benefits. In evaluating drug trials, separation of hypertension as compared with atherosclerotic events is important. Trials that focus on prevention of hyperte...

    journal_title:Current hypertension reports

    pub_type: 杂志文章

    doi:10.1007/s11906-999-0046-1

    authors: Kuller LH

    更新日期:1999-08-01 00:00:00

  • Neuroprotective mechanisms of the ACE2-angiotensin-(1-7)-Mas axis in stroke.

    abstract::The discovery of beneficial neuroprotective effects of the angiotensin converting enzyme 2-angiotensin-(1-7)-Mas axis [ACE2-Ang-(1-7)-Mas] in ischemic and hemorrhagic stroke has spurred interest in a more complete characterization of its mechanisms of action. Here, we summarize findings that describe the protective ro...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-014-0512-2

    authors: Bennion DM,Haltigan E,Regenhardt RW,Steckelings UM,Sumners C

    更新日期:2015-02-01 00:00:00

  • Neurogenic factors in renal hypertension.

    abstract::Hypertension is very common in patients with chronic renal failure and contributes to cardiovascular morbidity and mortality. Several mechanisms may contribute to hypertension in these patients, but recently a large body of evidence supports the notion that activation of the sympathetic nervous system (SNS) may play a...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-002-0016-3

    authors: Campese VM,Krol E

    更新日期:2002-06-01 00:00:00

  • Epidemiology of pulmonary arterial hypertension.

    abstract::The epidemiology of pulmonary arterial hypertension (PAH) has changed over the last decade. Remarkable advances in understanding the pathobiology and clinical care required in PAH have resulted in improved quality of life and survival. Despite such important progress, the long-term rate of survival is still unacceptab...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-013-0397-5

    authors: Jiang X,Jing ZC

    更新日期:2013-12-01 00:00:00

  • Mineralocorticoid Receptor and Endothelial Dysfunction in Hypertension.

    abstract:PURPOSE OF REVIEW:To review the latest reports of the contributions of the endothelial mineralocorticoid receptor to endothelial dysfunction and hypertension to begin to determine the clinical potential for this pathway for hypertension treatment. RECENT FINDINGS:Endothelial mineralocorticoid receptor expression is se...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-019-0981-4

    authors: Faulkner JL,Belin de Chantemèle EJ

    更新日期:2019-09-04 00:00:00

  • Dysfunctional brain-bone marrow communication: a paradigm shift in the pathophysiology of hypertension.

    abstract::It is widely accepted that the pathophysiology of hypertension involves autonomic nervous system dysfunction, as well as a multitude of immune responses. However, the close interplay of these systems in the development and establishment of high blood pressure and its associated pathophysiology remains elusive and is t...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-013-0361-4

    authors: Santisteban MM,Zubcevic J,Baekey DM,Raizada MK

    更新日期:2013-08-01 00:00:00

  • Renin inhibitors: optimal strategy for renal protection.

    abstract::Diabetic nephropathy and hypertension are the major causes of chronic kidney disease. The renin system plays a key role in the control of blood pressure (BP), as well as in the regulation of renal and adrenal function. Chronic activation of the renin system can lead to organ damage, particularly renal damage; increasi...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-007-0076-5

    authors: Schmieder RE

    更新日期:2007-11-01 00:00:00

  • Intrarenal Angiotensin-Converting Enzyme: the Old and the New.

    abstract:PURPOSE OF REVIEW:The intrarenal renin-angiotensin-aldosterone system (RAS) is an independent paracrine hormonal system with an increasingly prominent role in hypertension and renal disease. Two enzyme components of this system are angiotensin-converting enzyme (ACE) and more recently discovered ACE2. The purpose of th...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-017-0778-2

    authors: Culver S,Li C,Siragy HM

    更新日期:2017-09-19 00:00:00

  • Prevalence and diagnosis of primary aldosteronism.

    abstract::Primary aldosteronism (PA) is a common cause of arterial hypertension: in the PA Prevalence in Hypertensives (PAPY) Study, the prevalence of PA was 11.2% in consecutive referred hypertensive patients. When adrenal vein sampling (AVS) is available, two thirds of the cases can be attributed to a tumor and one third of c...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-010-0134-2

    authors: Rossi GP

    更新日期:2010-10-01 00:00:00

  • Hypertension in multicultural and minority populations: linking communication to compliance.

    abstract::Cardiovascular disease disproportionately affects minority populations, in part because of multiple sociocultural factors that directly affect compliance with antihypertensive medication regimens. Compliance is a complex health behavior determined by a variety of socioeconomic, individual, familial, and cultural facto...

    journal_title:Current hypertension reports

    pub_type: 杂志文章

    doi:10.1007/BF03215777

    authors: Betancourt JR,Carrillo JE,Green AR

    更新日期:1999-12-01 00:00:00

  • Combination therapy as first-line treatment for hypertension.

    abstract::With the cut-off point between "normal" and "high" blood pressure (BP) being pushed increasingly downward, especially for patients with multiple cardiovascular risk factors, most hypertensives need more than one antihypertensive agent to reach their target BP. In this article, we examine the rationale for combining dr...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-004-0020-x

    authors: Gavras I,Rosenthal T

    更新日期:2004-08-01 00:00:00

  • Hypertension in postmenopausal women.

    abstract::Blood pressure is typically lower in premenopausal women than in men. However, after menopause, the prevalence of hypertension in women is higher than it is in men. Hypertension is a major risk factor for cardiovascular disease in women and men, but cardiovascular disease is the leading cause of death in women. Furthe...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-012-0260-0

    authors: Lima R,Wofford M,Reckelhoff JF

    更新日期:2012-06-01 00:00:00

  • Mechanism of action of angiotensin-receptor blocking agents.

    abstract::Angiotensin II is the most active hormone of the renin-angiotensin system. In humans, two angiotensin receptors have been identified: AT(1) and AT(2). In adults, most of the effects of angiotensin II are mediated by the AT(1) receptor; the function of the AT(2) receptor is not yet well established. Angiotensin II has ...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-999-0036-3

    authors: Siragy HM,Bedigian M

    更新日期:1999-08-01 00:00:00

  • Vasopeptidase inhibition and endothelial function in hypertension.

    abstract::Vasopeptidase inhibitors are a new class of drugs capable of inhibiting both angiotensin-converting enzyme and neutral endopeptidase 24.11. This involves simultaneous inhibition with a single molecule of two key enzymes, ACE and NEP, which are both involved in the regulation of cardiovascular homeostasis in many ways....

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-001-0101-z

    authors: d'Uscio LV,Lüscher TF

    更新日期:2001-12-01 00:00:00

  • The L-arginine-nitric oxide pathway in hypertension.

    abstract::Nitric oxide is involved in the regulation of resting vascular tone, adaptation of blood flow to metabolic demand of tissue, and adaptation of vessel diameter to volume of inflow, ie, flow-mediated dilation. Arterial hypertension is associated with an increased vascular tone of resistance vessels, a reduced compliance...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-003-0015-z

    authors: Kelm M

    更新日期:2003-02-01 00:00:00

  • Management of hypertension in patients with coronary artery disease.

    abstract::Hypertension is present in three of four patients with coronary artery disease (CAD) but remains largely uncontrolled in most patients. Treating hypertension in these patients is complicated by the concern of precipitating coronary ischemia when diastolic blood pressure (DBP) is reduced excessively. However, an emergi...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-008-0066-2

    authors: Vongpatanasin W

    更新日期:2008-10-01 00:00:00

  • Pathophysiology of hypertension in the absence of nitric oxide/cyclic GMP signaling.

    abstract::The nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling system is a well-characterized modulator of cardiovascular function, in general, and blood pressure, in particular. The availability of mice mutant for key enzymes in the NO-cGMP signaling system facilitated the identification of interactions with o...

    journal_title:Current hypertension reports

    pub_type: 杂志文章

    doi:10.1007/s11906-012-0320-5

    authors: Thoonen R,Sips PY,Bloch KD,Buys ES

    更新日期:2013-02-01 00:00:00

  • Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection.

    abstract:PURPOSE OF REVIEW:In chronic kidney disease (CKD), plasma uric acid levels are increased because of the decrease in glomerular filtration rate. However, in addition to CKD, hyperuricemia is frequently associated with a number of other conditions such as hypertension, type 2 diabetes, obesity, and heart failure, overwei...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-020-01116-3

    authors: Kielstein JT,Pontremoli R,Burnier M

    更新日期:2020-10-31 00:00:00

  • The Role of Interleukin-10 in the Pathophysiology of Preeclampsia.

    abstract:PURPOSE OF REVIEW:The pathophysiology of preeclampsia is complex and not entirely understood. A key feature in preeclampsia development is an immunological imbalance that shifts the maternal immune response from one of tolerance towards one promoting chronic inflammation and endothelial dysfunction. As a key regulator ...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-018-0833-7

    authors: Cubro H,Kashyap S,Nath MC,Ackerman AW,Garovic VD

    更新日期:2018-04-30 00:00:00

  • Cognitive function in hypertensive children.

    abstract::Young hypertensive adults demonstrate decreased performance on neurocognitive testing compared with that of normotensive controls. There is emerging, preliminary evidence that children with hypertension also manifest cognitive differences when compared to normotensive controls. These preliminary studies consist mostly...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-014-0508-y

    authors: Lande MB,Kupferman JC

    更新日期:2015-01-01 00:00:00

  • The epithelial sodium channel in hypertension.

    abstract::Our understanding of Na(+) transport defects has exploded in the past several years, and has provided unique insights into epithelial transport processes, and unusual clinical syndromes resulting from mutations of specific ion transporters. These genetic disorders affect Na(+) balance, with both Na(+) retaining and Na...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-999-0013-x

    authors: Warnock DG

    更新日期:1999-04-01 00:00:00

  • Epithelial sodium channel, salt intake, and hypertension.

    abstract::The epithelial sodium channel (ENaC) is a membrane protein made of three different but homologous subunits (a, b, and g) present in the apical membrane of epithelial cells of, for example, the distal nephron. This channel is responsible for salt reabsorption in the kidney and can cause human diseases by increasing cha...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-003-0005-1

    authors: Hummler E

    更新日期:2003-02-01 00:00:00

  • Insulin resistance in HIV-related lipodystrophy.

    abstract::Lipodystrophy (LD) associated with HIV infection is a syndrome of abnormal fat distribution observed in HIV-infected patients treated with various antiretroviral agents. In addition, insulin resistance and dyslipidemia can occur in HIV-infected patients with or without LD. The demonstration of the latter metabolic dis...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-003-0067-0

    authors: Mikhail N

    更新日期:2003-04-01 00:00:00

  • Statins and blood pressure regulation.

    abstract::Hypertension and high serum cholesterol levels are two of the most relevant risk factors for cardiovascular diseases. A combined increase in both risk factors has been reported in a significant proportion of patients with coronary artery disease. Statins are the most widely used drugs to treat hypercholesterolemia, an...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-001-0090-y

    authors: Borghi C,Veronesi M,Prandin MG,Dormi A,Ambrosioni E

    更新日期:2001-08-01 00:00:00

  • Chronic kidney disease and albuminuria in arterial hypertension.

    abstract::Chronic kidney disease is a major public health problem worldwide: it is estimated that in the general population, 1 person in 10 has some degree of renal damage. Adequate blood pressure control represents the mainstay of treatment, to delay deterioration of renal function and prevent cardiovascular complications. Cur...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-010-0141-3

    authors: Leoncini G,Viazzi F,Pontremoli R

    更新日期:2010-10-01 00:00:00

  • New therapeutic approaches to resistant hypertension.

    abstract::Resistant hypertension is a common and growing clinical problem characterized by failure to achieve target blood pressure levels despite adequate use of at least three antihypertensive agents. Although numerous safe and effective pharmacologic therapies are available to treat elevated blood pressure, novel therapeutic...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-010-0119-1

    authors: Schlaich MP,Krum H,Esler MD

    更新日期:2010-08-01 00:00:00

  • Chlorthalidone: mechanisms of action and effect on cardiovascular events.

    abstract::How chlorthalidone (CTDN) reduces risk for cardiovascular events (CVEs) can be considered in light of its ability to lower blood pressure (BP) and its non-BP related, pleiotropic effects. The mechanism by which CTDN lowers BP is unclear but may include alterations in whole body regulation and vasodilatory actions on v...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-013-0372-1

    authors: Roush GC,Buddharaju V,Ernst ME,Holford TR

    更新日期:2013-10-01 00:00:00